For information and guidance relating to Ibandronic Acid 50mg tablets as adjuvant therapy in early breast cancer on the SY MO website click here
Alendronic Acid Tablets
Adrenocortical Function Testing and Antidiuretic Hormone Disorders
(and Other Hormone-Relate Disorders)
| Pack | Price |
|---|---|
| 4 tablet | £0.97 |
Bisphosphonate
Hypercalcaemia, Paget’s Disease
Pamidronate Disodium Injection 15mg and 30mg Injection
*Hospital Use Only*
Adjuvant bisphosphonate therapy in breast cancer
Rationale 1
*Hospital Use Only*
Bone malignancies and Pagets disease
Rationale 1
*Hospital Use Only*
NICE TA464 Bisphosphonates for treating osteoporosis
NICE NG35 Myeloma: diagnosis and management
Bone malignancies and Pagets disease, Treat osteoporosis in men and reduce risk of new fractures following hip fracture
Rationale 1
*Hospital Use Only*
NICE TA464 recommends as treatment for osteoporosis
NICE NG35 Myeloma: diagnosis and management
Osteoporosis (prevention) in postmenopausal women at increased risk of fractures
Men with increase risk of fracture
Refer to the Clinical Guideline For Denosumab 60mg/ml Injection
Currently advising to prescribe by brand Stoboclo when available.
MHRA - Drug Safety Update & NHS England Patient Safety alerts May 2022 ‘Denosumab should not be prescribed to anyone under the age of 18 years’
Denosumab is Amber for the following indications;
Denosumab (60mg subcutaneous injection every 6 months) is licensed for the treatment of:
(a) osteoporosis in postmenopausal women and in men at increased risk of fractures due to
osteoporosis
(b) bone loss associated with hormone ablation in men with prostate cancer at increased risk of
fractures
(c) bone loss associated with long term systemic glucocorticoid therapy in patients at increased
risk of fractures
Please note 120mg strength (XGEVA) is RED
| Pack | Price |
|---|---|
| 1 pre-filled disposable injection | £183.00 |